Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management guidelines for hyperthyroidism

J A Franklyn1

  • 1Department of Medicine, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, UK.

Bailliere'S Clinical Endocrinology and Metabolism
|April 9, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Triiodothyronine regulates angiogenic growth factor and cytokine secretion by isolated human decidual cells in a cell-type specific and gestational age-dependent manner.

Human reproduction (Oxford, England)·2014
Same author

Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumors.

The Journal of clinical endocrinology and metabolism·2013
Same author

Expression and function of thyroid hormone transporters in the microvillous plasma membrane of human term placental syncytiotrophoblast.

Endocrinology·2012
Same author

PTTG-binding factor (PBF) is a novel regulator of the thyroid hormone transporter MCT8.

Endocrinology·2012
Same author

The expression of thyroid hormone transporters in the human fetal cerebral cortex during early development and in N-Tera-2 neurodifferentiation.

The Journal of physiology·2011
Same author

Differential triiodothyronine responsiveness and transport by human cytotrophoblasts from normal and growth-restricted pregnancies.

The Journal of clinical endocrinology and metabolism·2010
Same journal

Phytoestrogen content in foods.

Bailliere's clinical endocrinology and metabolism·1999
Same journal

Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data.

Bailliere's clinical endocrinology and metabolism·1999
Same journal

Experimental studies on lignans and cancer.

Bailliere's clinical endocrinology and metabolism·1999
Same journal

Reproductive actions of phytoestrogens.

Bailliere's clinical endocrinology and metabolism·1999
Same journal

Phytoestrogens and inhibition of angiogenesis.

Bailliere's clinical endocrinology and metabolism·1999
Same journal

Phytoestrogens and diseases of the prostate gland.

Bailliere's clinical endocrinology and metabolism·1999
See all related articles

Effective treatments exist for Graves' hyperthyroidism, including anti-thyroid drugs, surgery, and radioiodine. This study outlines UK guidelines to address the lack of consensus on choosing the best treatment for individual patients.

Area of Science:

  • Endocrinology
  • Internal Medicine
  • Clinical Practice Guidelines

Background:

  • Graves' hyperthyroidism has multiple effective treatments: anti-thyroid drugs, surgery, and radioiodine.
  • A significant lack of consensus exists regarding the optimal treatment choice for specific hyperthyroid cases.
  • This ambiguity necessitates standardized clinical management approaches.

Purpose of the Study:

  • To develop United Kingdom-based guidelines for the management of hyperthyroidism.
  • To establish a consensus statement for good practice in hyperthyroid patient care.
  • To identify and address outstanding contentious issues in Graves' hyperthyroidism management.

Main Methods:

  • A consensus development process was employed to create the guidelines.

Related Experiment Videos

  • Audit measures were designed to assess adherence to the developed guidelines.
  • Literature review and expert opinion likely informed the guideline creation.

    • Main Results:

    • A United Kingdom consensus statement on hyperthyroidism management has been developed.
    • Associated audit measures have been created to evaluate guideline implementation.
    • Several contentious issues in Graves' hyperthyroidism treatment remain unresolved.

    Conclusions:

    • The developed guidelines aim to improve consistency in hyperthyroidism treatment.
    • Audit measures will facilitate the evaluation of guideline effectiveness.
    • Further research and discussion are needed to resolve remaining management controversies.